WEBULL
WebtradeDownload

IDI (ENXTPA:IDIP) Stock Grapples With Whether 84.7% Margins Can Last

Simply Wall St · 2d ago

IDI walked into this earnings print with a flat share price over the past three months and a low P/E of 4.9x, already priced as a problem child. The H1 2026 report did the opposite of calming that view. Net income from continuing operations over the last twelve months sat at €101.3 million on revenue of €119.6 million, which implies an 84.7% margin that looks almost unreal for a capital markets player. The emotional tug of a cheap multiple collides with the question every holder now has in mind: How durable is that profitability profile?

Is IDI trading at a genuine discount, or is that 4.9x P/E just masking earnings that could come under pressure? Compare the cheap headline multiple with the detailed assumptions baked into our valuation analysis for IDI.

H1 2026 Earnings Summary

  • Revenue (H1 2026 vs. H1 2025): €66.7 million vs. €28.149 million (up about 137%)
  • Net Income from Continuing Operations, Excluding Extra Items (H1 2026 vs. H1 2025): €57.1 million vs. €15.065 million (up almost 4x)
  • Basic EPS (H2 2025 vs. H1 2025): €6.35 vs. €2.05 (up about 210%)
  • Net Profit Margin, Trailing 12 Months (2026 H1 vs. prior year): 84.7% vs. 58.1% (margin expanded sharply)

Prefer clear visuals instead of another dense block of earnings figures for IDI? See the full picture of the business, including a concise view of its valuation, in the interactive company report for IDI.

ENXTPA:IDIP Trailing 12-Month Earnings & Revenue History as at Sep 2026
ENXTPA:IDIP Trailing 12-Month Earnings & Revenue History as at Sep 2026

IDI earnings that back a bullish story

For anyone arguing IDI is a solid listed gateway to European private equity, these figures give the story some muscle. Revenue in H1 2026 almost tripled against H1 2025, while net income from continuing operations excluding extra items was close to 4x higher. The trailing net profit margin of 84.7% on €119.6 million of revenue shows a very profitable investing model over the last year. Short term price moves have been slightly weak, yet the recent operating profile still lines up with a constructive view on the business.

Where the recent IDI numbers worry bears

Anyone cautious on IDI will focus on whether such high profitability can hold. An 84.7% trailing margin in a capital markets and private equity vehicle raises questions about sustainability, given the lumpiness that often comes with exits and fair value marks. The stock has slipped over the past week and month, which hints at some market hesitation despite the strong H1 2026 snapshot. That mix of exceptional recent earnings and softer trading performance keeps concerns about earnings durability firmly on the table.

Compare IDI's punchy H1 profitability with how the Street is reacting to the flat share price around €69.8 since the report. See the consensus price target analysis for IDI to check whether analysts think this earnings run can justify a different path from here.

Take Control of Your Next Move

If the mix of a low P/E and very high recent profitability at IDI has your attention, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and wait for a setup that fits your plan. After you build a position, manage the rest of your holdings through the Portfolio Command Center so you filter out background noise and only see updates that matter for your thesis. For longer term decision making, plug into the Community to see how other investors are thinking about the same risks and potential catalysts. That combination helps you spot both upside triggers and early warning signs before they hit the wider market.

Curious About Alternatives To IDI?

Fresh ideas move fast. Breakout themes, early momentum and stocks still flying under the radar for now can get caught quickly, so review new ideas and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.